Connection

Stephen Tomlinson to Biological Products

Back to Details
This is a "connection" page, showing publications Stephen Tomlinson has written about Biological Products.
Stephen Tomlinson
Connection Strength
0.042
Biological Products
  1. A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor. Virol J. 2012 Nov 23; 9:285.
    View in: PubMed
    Score: 0.023
  2. A new therapeutic strategy for lung tissue injury induced by influenza with CR2 targeting complement inhibitor. Virol J. 2010 Feb 09; 7:30.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.